Page 5,050«..1020..5,0495,0505,0515,052..5,0605,070..»

The Alliance for Regenerative Medicine Holds Third Annual Stem Cell Meeting on the Mesa Regen Med Partnering Forum

Posted: Published on July 17th, 2013

WASHINGTON, DC--(Marketwired - Jul 16, 2013) - The Alliance for Regenerative Medicine (ARM), the international organization representing the interests of the regenerative medicine community, today announced that the third annual Regen Med Partnering Forum will take place October 14 and 15, 2013 as part of the Stem Cell Meeting on the Mesa. This forum is the only partnering meeting organized specifically for the regenerative medicine field, and has become the premier gathering place for more than 300 senior level executives seeking opportunities to collaborate and learn more about recent advances in the space. Life Technologies Corporation (NASDAQ: LIFE) is the meeting's founding and platinum-level sponsor. The Regen Med Partnering Forum will take place at the Estancia La Jolla Hotel & Spa, La Jolla, California. The Stem Cell Meeting on the Mesa's eighth Annual Scientific Symposium will immediately follow the Regen Med Partnering Forum on October 16, 2013 at the Salk Institute for Biological Studies. The Scientific Symposium, organized by the Sanford Consortium for Regenerative Medicine, is attended by leading scientists and researchers in the field, as well as participants from the business and patient advocacy communities. Combined, these meetings will attract over 800 attendees from around the globe, highlighting the … Continue reading

Comments Off on The Alliance for Regenerative Medicine Holds Third Annual Stem Cell Meeting on the Mesa Regen Med Partnering Forum

What are mesenchymal stem cells and how can they be used for osteoarthritis treatment? – Video

Posted: Published on July 16th, 2013

What are mesenchymal stem cells and how can they be used for osteoarthritis treatment? http://www.stemcellsarthritistreatment.com Stem cells in the adult can come from blood sources or from non-blood sources. Mesenchymal stem cells or mesenchym... By: Nathan Wei … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on What are mesenchymal stem cells and how can they be used for osteoarthritis treatment? – Video

Long lasting blood vessels created in mice using human stem cells

Posted: Published on July 16th, 2013

Washington, July 16 (ANI): Researchers at Massachusetts General Hospital (MGH) have used vascular precursor cells derived from human induced pluripotent stem cells (iPSCs) to generate, in mice, functional blood vessels that lasted as long as nine months. In their report, the investigators describe using iPSCs - reprogrammed adult cells that have many of the characteristics of embryonic stem cells - from both healthy adults and from individuals with type 1 diabetes to generate blood vessels on the outer surface of the brain or under the skin of mice. "The discovery of ways to bring mature cells back to a 'stem-like' state that can differentiate into many different types of tissue has brought enormous potential to the field of cell-based regenerative medicine, but the challenge of deriving functional cells from these iPSCs still remains," Rakesh Jain, PhD, director of the Steele Laboratory for Tumor Biology at MGH and co-senior author of the study, said. "Our team has developed an efficient method to generate vascular precursor cells from human iPSCs and used them to create networks of engineered blood vessels in living mice," he said. The ability to regenerate or repair blood vessels could make a crucial difference in the treatment of … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Long lasting blood vessels created in mice using human stem cells

“Functional” blood vessels made from stem cells

Posted: Published on July 16th, 2013

A team of scientists has been able to engineer stable and functional blood vessels in mice using induced pluripotent stem (iPS) cells taken from humans. The blood vessels lasted for 280 days in the brain of the mice. The scientists are from Massachusetts General Hospital, Boston, and Harvard Stem Institute, Harvard University. The skin cells of healthy people and those with Type I diabetes were used to produce iPS cell lines, and, in turn, the blood vessels. The results of the study are published online on July 16 in the Proceedings of the National Academy of Sciences (PNAS) journal. This work is proof of concept demonstration that vascular precursor cells endothelial precursor cells and mesenchymal precursor cells from iPS cells can be used to engineer blood vessels. While endothelial cells form the inner lining of blood vessels, mesenchymal cells provide structural stability. 3 specific markers The method of deriving these two cells from iPS cells was by using three specific markers. The way we did it enabled us to engineer blood vessels in vivo [inside the mice] using sophisticated microscopy and mouse models, said Dr. Rekha Samuel, Professor of Pathology at the Centre for Stem Cell Research, CMC, Vellore, Tamil … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on “Functional” blood vessels made from stem cells

Researchers generate long-lasting blood vessels from reprogrammed human cells

Posted: Published on July 16th, 2013

July 15, 2013 Massachusetts General Hospital (MGH) researchers have used vascular precursor cells derived from human induced pluripotent stem cells (iPSCs) to generate, in an animal model, functional blood vessels that lasted as long as nine months. In their report being published in PNAS Early Edition, the investigators describe using iPSCs -- reprogrammed adult cells that have many of the characteristics of embryonic stem cells -- from both healthy adults and from individuals with type 1 diabetes to generate blood vessels on the outer surface of the brain or under the skin of mice. "The discovery of ways to bring mature cells back to a 'stem-like' state that can differentiate into many different types of tissue has brought enormous potential to the field of cell-based regenerative medicine, but the challenge of deriving functional cells from these iPSCs still remains," says Rakesh Jain, PhD, director of the Steele Laboratory for Tumor Biology at MGH and co-senior author of the study. "Our team has developed an efficient method to generate vascular precursor cells from human iPSCs and used them to create networks of engineered blood vessels in living mice." The ability to regenerate or repair blood vessels could make a crucial difference … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Researchers generate long-lasting blood vessels from reprogrammed human cells

Steering stem cells with magnets: Proof of concept for clinical applications

Posted: Published on July 16th, 2013

Javascript is currently disabled in your web browser. For full site functionality, it is necessary to enable Javascript. In order to enable it, please see these instructions. 50 minutes ago Magnetic iron oxide particles could be used to help doctors direct stem cells to particular parts of the body. Here, a bar magnet was applied to the tail during injection. Otherwise most of the cells (labeled with a fluorescent dye) end up in the liver and lungs. Magnets could be a tool for directing stem cells' healing powers to treat conditions such as heart disease or vascular disease. By feeding stem cells tiny particles made of iron oxide, scientists at Emory and Georgia Tech can use magnets to attract the cells to a particular location in the body after intravenous injection. The results are published online in the journal Small and will appear in an upcoming issue. The paper was a result of collaboration between the laboratories of W. Robert Taylor, MD, PhD, and Gang Bao, PhD. Taylor is professor of medicine and biomedical engineering and director of the Division of Cardiology at Emory University School of Medicine. Bao is professor in the Wallace H. Coulter Department of Biomedical Engineering … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Steering stem cells with magnets: Proof of concept for clinical applications

Adult Human Cells Used To Create Long-Lived Blood Vessels

Posted: Published on July 16th, 2013

redOrbit Staff & Wire Reports Your Universe Online Massachusetts General Hospital (MGH) researchers have managed to create long-lasting blood vessels from reprogrammed human induced pluripotent stem cells (iPSCs), This groundbreaking research is published in the latest issue of the Proceedings of the National Academy of Sciences (PNAS) Early Edition. Using vascular precursor cells derived from iPSCs, reprogrammed adult cells that have several of the same characteristics of embryonic stem cells, the scientists were able to create functional blood vessels in an animal model that lasted up to nine months. In their study, the authors describe how they used cells from both healthy adults and those with type 1 diabetes to generate blood vessels under the skin or on the brains outer surface in mice. The discovery of ways to bring mature cells back to a stem-like state that can differentiate into many different types of tissue has brought enormous potential to the field of cell-based regenerative medicine, but the challenge of deriving functional cells from these iPSCs still remains, said co-author Rakesh Jain, director of the MGH Steele Laboratory for Tumor Biology. Our team has developed an efficient method to generate vascular precursor cells from human iPSCs and used them … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Adult Human Cells Used To Create Long-Lived Blood Vessels

Steering stem cells with magnets

Posted: Published on July 16th, 2013

Public release date: 16-Jul-2013 [ | E-mail | Share ] Contact: Quinn Eastman qeastma@emory.edu 404-727-7829 Emory Health Sciences Magnets could be a tool for directing stem cells' healing powers to treat conditions such as heart disease or vascular disease. By feeding stem cells tiny particles made of iron oxide, scientists at Emory and Georgia Tech can use magnets to attract the cells to a particular location in the body after intravenous injection. The results are published online in the journal Small and will appear in an upcoming issue. The paper was a result of collaboration between the laboratories of W. Robert Taylor, MD, PhD, and Gang Bao, PhD. Taylor is professor of medicine and biomedical engineering and director of the Division of Cardiology at Emory University School of Medicine. Bao is professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. Co-first authors of the paper are postdoctoral fellows Natalia Landazuri, PhD, and Sheng Tong, PhD. Landazuri is now at the Karolinska Institute in Sweden. The type of cells used in the study, mesenchymal stem cells, are not embryonic stem cells. Mesenchymal stem cells can be readily obtained from adult tissues such as bone … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Steering stem cells with magnets

Medistem Files Registration Statement With Securities and Exchange Commission

Posted: Published on July 16th, 2013

SAN DIEGO, CA--(Marketwired - Jul 15, 2013) - Medistem, Inc. (PINKSHEETS: MEDS), announced today that it has filed a Form 10 registration statement with the Securities and Exchange Commission. The filing is part of the Company's strategy to become fully reporting and access the public capital markets. It is expected that the Form 10 will become effective 60 days from the filing date, allowing liquidity for existing shareholders. In 2009, the Company voluntarily elected to stop reporting under the 1934 Securities and Exchange Act to focus its resources on advancing its lead product, ERC-124, a universal donor stem cell. The Company successfully obtained FDA clearance to initiate clinical trials for its product in patients with critical limb ischemia (CLI). In addition, the Company has treated 18 congestive heart failure (CHF) patients in an ongoing double-blind placebo controlled trial. On October 2012, the Company strengthened its management team with the addition of biopharmaceutical veteran Alan J. Lewis, Ph.D. as Chief Executive Officer. Dr. Lewis has previously served as CEO and Chairman of Ambit BioSciences, CEO of the Juvenile Diabetes Research Foundation, President, CEO and Director of Novocell, Inc., and CEO and Director of Signal Pharmaceuticals. Dr. Lewis also serves as a … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on Medistem Files Registration Statement With Securities and Exchange Commission

FDA gives green light to SynGen for cord blood-processing products

Posted: Published on July 16th, 2013

Buoyed by another round of multimillion-dollar financing, Sacramento-based startup SynGen Inc. has cleared a significant federal hurdle to get its cord blood-processing products on the market. The midtown Sacramento medical device startup, which develops stem cell harvesting systems, announced Monday that it has received U.S. Food and Drug Administration clearance to market three related products to process cord blood. All three are related to the company's SynGenX-1000 system, which harvests stem and progenitor cells from units of collected umbilical cord blood. The company says harvested cells can be used for treatment of numerous medical conditions, including leukemia, lymphoma and more than 70 genetic diseases. "We thank the FDA for guiding us through the clearance process. SynGen is dedicated to developing products that consistently exceed our customers' expectations," said Philip Coelho, company president and CEO. Last year, SynGen received $5 million from San Francisco venture capital firm Bay City Capital LLC to further develop what Coelho has called the next generation in stem cell harvesting systems. SynGen recently received additional financing of up to $3 million from Bay City. Established in 1997, Bay City bills itself as a "life sciences venture capital firm investing in opportunities across the various life sciences … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on FDA gives green light to SynGen for cord blood-processing products

Page 5,050«..1020..5,0495,0505,0515,052..5,0605,070..»